Share-based Payment Arrangement, Expense in USD of Astria Therapeutics, Inc. from 2013 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Astria Therapeutics, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from 2013 to Q3 2025.
  • Astria Therapeutics, Inc. Share-based Payment Arrangement, Expense for the quarter ending September 30, 2025 was $4.31M, a 25.5% increase year-over-year.
  • Astria Therapeutics, Inc. Share-based Payment Arrangement, Expense for the twelve months ending September 30, 2025 was $15.9M.
  • Astria Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2024 was $13M, a 107% increase from 2023.
  • Astria Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $6.31M, a 38.6% increase from 2022.
  • Astria Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $4.55M, a 35.5% increase from 2021.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Growth (%)

Astria Therapeutics, Inc. Quarterly Share-based Payment Arrangement, Expense (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2025 $15.9M $4.31M +$874K +25.5% Jul 1, 2025 Sep 30, 2025 10-Q 2025-11-12
Q2 2025 $15M $4.35M +$900K +26.1% Apr 1, 2025 Jun 30, 2025 10-Q 2025-08-12
Q1 2025 $14.1M $3.84M +$1.09M +39.4% Jan 1, 2025 Mar 31, 2025 10-Q 2025-05-13
Q4 2024 $13M $3.4M Oct 1, 2024 Dec 31, 2024 10-K 2025-03-11
Q3 2024 $3.43M Jul 1, 2024 Sep 30, 2024 10-Q 2025-11-12
Q2 2024 $3.45M Apr 1, 2024 Jun 30, 2024 10-Q 2025-08-12
Q1 2024 $2.75M Jan 1, 2024 Mar 31, 2024 10-Q 2025-05-13
Q4 2020 $1.39M $305K +$20K +7.02% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-10
Q3 2020 $1.37M $375K -$3K -0.79% Jul 1, 2020 Sep 30, 2020 10-Q 2020-11-12
Q2 2020 $1.37M $371K -$70K -15.9% Apr 1, 2020 Jun 30, 2020 10-Q 2020-08-10
Q1 2020 $1.44M $339K -$69K -16.9% Jan 1, 2020 Mar 31, 2020 10-Q 2020-05-12
Q4 2019 $1.51M $285K -$145K -33.7% Oct 1, 2019 Dec 31, 2019 10-K/A 2021-04-19
Q3 2019 $1.66M $378K -$38K -9.14% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-12
Q2 2019 $1.7M $441K -$5K -1.12% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-10
Q1 2019 $1.7M $408K -$71K -14.8% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-12
Q4 2018 $1.77M $430K -$76K -15% Oct 1, 2018 Dec 31, 2018 10-K 2020-03-10
Q3 2018 $1.85M $416K -$99K -19.2% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-07
Q2 2018 $1.95M $446K -$35K -7.28% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-08
Q1 2018 $1.98M $479K -$26K -5.15% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-14
Q4 2017 $2.01M $506K -$79K -13.5% Oct 1, 2017 Dec 31, 2017 10-K 2019-03-14
Q3 2017 $2.09M $515K +$5K +0.98% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-13
Q2 2017 $2.08M $481K -$36K -6.96% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-09
Q1 2017 $2.12M $505K -$43K -7.85% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-10
Q4 2016 $2.16M $585K +$70K +13.6% Oct 1, 2016 Dec 31, 2016 10-K 2018-03-15
Q3 2016 $2.09M $510K +$22K +4.51% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-09
Q2 2016 $2.07M $517K +$163K +46% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-10
Q1 2016 $1.91M $548K +$247K +82.1% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-11
Q4 2015 $1.66M $515K Oct 1, 2015 Dec 31, 2015 10-K 2018-03-15
Q3 2015 $488K +$256K +110% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-10
Q2 2015 $354K +$126K +55.3% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-11
Q1 2015 $301K Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-12
Q3 2014 $232K Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-12
Q2 2014 $228K Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-13

Astria Therapeutics, Inc. Annual Share-based Payment Arrangement, Expense (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 $13M +$6.73M +107% Jan 1, 2024 Dec 31, 2024 10-K 2025-03-11
2023 $6.31M +$1.76M +38.6% Jan 1, 2023 Dec 31, 2023 10-K 2025-03-11
2022 $4.55M +$1.19M +35.5% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-04
2021 $3.36M +$1.97M +142% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-22
2020 $1.39M -$122K -8.07% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-10
2019 $1.51M -$259K -14.6% Jan 1, 2019 Dec 31, 2019 10-K/A 2021-04-19
2018 $1.77M -$236K -11.8% Jan 1, 2018 Dec 31, 2018 10-K 2020-03-10
2017 $2.01M -$153K -7.08% Jan 1, 2017 Dec 31, 2017 10-K 2019-03-14
2016 $2.16M +$502K +30.3% Jan 1, 2016 Dec 31, 2016 10-K 2018-03-15
2015 $1.66M +$761K +84.8% Jan 1, 2015 Dec 31, 2015 10-K 2018-03-15
2014 $897K +$554K +162% Jan 1, 2014 Dec 31, 2014 10-K 2017-03-16
2013 $343K Jan 1, 2013 Dec 31, 2013 10-K 2016-03-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.